
Please try another search
Pre-Open Stock Movers:
Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE:PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of NURTEC® ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults.
Upstart Holdings (NASDAQ:UPST) 57% LOWER; reported Q1 EPS of $0.61, $0.07 better than the analyst estimate of $0.54. Revenue for the quarter came in at $310 million versus the consensus estimate of $300.25 million. Upstart Holdings sees Q2 2022 revenue of $295-305 million, versus the consensus of $335 million.
Vroom (VRM) 53% HIGHER; reported Q1 EPS of ($0.71), $0.30 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $923.78 million versus the consensus estimate of $874.09 million.
GoodRx Holdings, Inc. (GDRX) 31% LOWER; reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $203.3 million versus the consensus estimate of $200.2 million. GoodRx Holdings, Inc. sees Q2 2022 revenue of $190 million, versus the consensus of $215.6 million.
Novavax (NASDAQ:NVAX) 25% LOWER; reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million. Novavax sees FY2022 revenue of $4-5 billion.
Duke Realty Corporation (NYSE:DRE) 19% HIGHER; Prologis , Inc. (NYSE:PLD), the global leader in logistics real estate, today sent a letter to James B. Connor, Chairman and Chief Executive Officer of Duke Realty Corporation (DRE) proposing to acquire Duke Realty in an all-stock transaction.
Peloton (NASDAQ:PTON) 17% LOWER; reported Q3 EPS of ($2.27), $1.42 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $964.3 million versus the consensus estimate of $972.88 million. Peloton sees Q4 2022 revenue of $675-700 million, versus the consensus of $821.7 million.
Shockwave Medical (NASDAQ:SWAV) 16% HIGHER; reported Q1 EPS of $0.41, $0.23 better than the analyst estimate of $0.18. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $86.41 million. Shockwave Medical sees Q2 2022 revenue of $435-455 million, versus the consensus of $417.9 million.
Clover (JO:CLRJ) Health Investments (CLOV) 14% HIGHER; reported revenue for the first quarter of $874.4 million versus the consensus estimate of $787.4 million. Clover Health Investments sees FY2022 revenue of $3-3.4 billion, versus the consensus of $3.24 billion.
Groupon (NASDAQ:GRPN) 12% LOWER; reported Q1 EPS of ($0.80), $0.28 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $153.3 million versus the consensus estimate of $165.81 million. Groupon sees Q2 2022 revenue of $155-165 million, versus the consensus of $202.4 million. Groupon sees FY2022 revenue of $670-700 million, versus the consensus of $837.08 million.
Hims & Hers Health, Inc. (HIMS) 7% HIGHER; reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $101.3 million versus the consensus estimate of $91.17 million. Hims & Hers Health, Inc. sees FY2022 revenue of $103-106 million, versus the consensus of $92.45 million. Hims & Hers Health, Inc. sees FY2022 revenue of $410-425 million, versus the consensus of $377.85 million.
RingCentral, Inc. (NYSE:RNG) 7% LOWER; reported Q1 EPS of $0.39, $0.05 better than the analyst estimate of $0.34. Revenue for the quarter came in at $468 million versus the consensus estimate of $458.67 million. RingCentral, Inc. sees Q2 2022 EPS of $0.40-$0.41, versus the consensus of $0.38. RingCentral, Inc. sees Q2 2022 revenue of $475.5-479.5 million, versus the consensus of $477.2 million. RingCentral, Inc. sees FY2022 EPS of $1.83-$1.87, versus the consensus of $1.71. RingCentral, Inc. sees FY2022 revenue of $1.99-2.015 billion, versus the consensus of $2.01 billion.
XPO Logistics (NYSE:XPO) 6% HIGHER; reported Q1 EPS of $1.25, $0.32 better than the analyst estimate of $0.93. Revenue for the quarter came in at $3.47 billion versus the consensus estimate of $3.22 billion. XPO Logistics sees FY2022 EPS of $5.20-$5.60, versus the consensus of $5.19.
Rover Group (ROVR) 5% HIGHER; reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $28 million versus the consensus estimate of $26.54 million. Rover Group sees Q2 2022 revenue of $41-43 million, versus the consensus of $41.2 million. Rover Group sees FY2022 revenue of $160-180 million, versus the consensus of $174.07 million.
Autoliv (NYSE:ALV), Inc. (ALV) 5% HIGHER; UBS upgraded from Neutral to Buy with a price target of $90.00 (from $103.00).
AMC Entertainment (NYSE:AMC) 5% HIGHER; reported Q1 EPS of ($0.52), $0.11 better than the analyst estimate of ($0.63). Revenue for the quarter came in at $785.7 million versus the consensus estimate of $736.23 million.
Microchip Technology (NASDAQ:MCHP) 4% HIGHER; reported Q4 EPS of $1.35, $0.10 better than the analyst estimate of $1.25. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.82 billion. Microchip Technology sees Q1 2023 EPS of $1.32-$1.36, versus the consensus of $1.28. Microchip Technology sees Q1 2023 revenue of $1.918-1.992 billion, versus the consensus of $1.86 billion.
Uber (NYSE:UBER) 4% HIGHER; CEO bought 200,000 shares
Blink Charging (BLNK) 3% HIGHER; reported Q1 EPS of ($0.36), $0.05 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.87 million.
Tiga Acquisition Corp. (TINV) 2% HIGHER; LGBTQ+ dating app Grindr will come public in a merger with the SPAC.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.